{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Higuchi kinetics", "Klebsiella pneumoniae", "bilosomes", "controlled release", "entrapment efficiency", "lung infection"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "36145264", "DateRevised": {"Year": "2022", "Month": "09", "Day": "28"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "08", "Day": "24"}], "Language": ["eng"], "ELocationID": ["1043", "10.3390/ph15091043"], "Journal": {"ISSN": "1424-8247", "JournalIssue": {"Volume": "15", "Issue": "9", "PubDate": {"Year": "2022", "Month": "Aug", "Day": "24"}}, "Title": "Pharmaceuticals (Basel, Switzerland)", "ISOAbbreviation": "Pharmaceuticals (Basel)"}, "ArticleTitle": "Bilosomes as Nanoplatform for Oral Delivery and Modulated In Vivo Antimicrobial Activity of Lycopene.", "Abstract": {"AbstractText": ["Owing to the disseminating resistance among pathogenic bacteria, especially <i>Klebsiella pneumoniae</i>, there is a high need for alternate compounds with antibacterial activity. Herein, lycopene was isolated from <i>Lycopersicon esculentum</i> L. Molecular docking approach was employed to explore lycopene binding affinity to selected vital proteins of <i>K. pneumoniae</i> with the binding mechanisms being investigated. This proposed a promising antibacterial activity of lycopene. However, the pharmacological use of lycopene is hampered by its poor solubility and limited oral bioavailability. Accordingly, bilosomes were fabricated for oral lycopene delivery. The computed entrapment efficiency, mean vesicular size, and zeta potential values for the optimized formulation were 93.2 \u00b1 0.6%, 485.8 \u00b1 35.3 nm, and -38.3 \u00b1 4, respectively. In vitro drug release studies revealed controlled lycopene release from constructed bilosomes, with the drug liberation being based on the Higuchi kinetics model. Transmission electron microscopic evaluation of bilosomes revealed spherical nanovesicles free from aggregates. Moreover, the in vitro and in vivo antibacterial activity of lycopene and its constructed formulations against multidrug-resistant <i>K. pneumoniae</i> isolates were explored. The optimized bilosomes exhibited the lowest minimum inhibitory concentrations ranging from 8 to 32 \u00b5g/mL. In addition, scanning electron microscopy revealed remarkable deformation and lysis of the bilosomes-treated bacterial cells. Regarding in vivo investigation, a lung infection model in mice was employed. The tested bilosomes reduced the inflammation and congestion in the treated mice's lung tissues, resulting in normal-sized bronchioles and alveoli with very few congested vessels. In addition, it resulted in a significant reduction in pulmonary fibrosis. In conclusion, this study investigated the potential activity of the naturally isolated lycopene in controlling infections triggered by multidrug-resistant <i>K. pneumoniae</i> isolates. Furthermore, it introduced bilosomes as a promising biocompatible nanocarrier for modulation of oral lycopene delivery and in vivo antimicrobial activity."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Science, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Binsuwaidan", "ForeName": "Reem", "Initials": "R"}, {"Identifier": ["0000-0002-8443-7351"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Technology, College of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "Sultan", "ForeName": "Amal A", "Initials": "AA"}, {"Identifier": ["0000-0003-0463-8047"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "Negm", "ForeName": "Walaa A", "Initials": "WA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Science, College of Pharmacy, Princess Nourah bint Abdulrahman University, P.O. Box 84428, Riyadh 11671, Saudi Arabia."}], "LastName": "Attallah", "ForeName": "Nashwah G M", "Initials": "NGM"}, {"Identifier": ["0000-0003-3013-1354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia."}], "LastName": "Alqahtani", "ForeName": "Moneerah J", "Initials": "MJ"}, {"Identifier": ["0000-0001-6033-7359"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy and Medicinal Plants, Faculty of Pharmacy (Boys), Al-Azhar University, Cairo 11884, Egypt."}], "LastName": "Hussein", "ForeName": "Ismail A", "Initials": "IA"}, {"Identifier": ["0000-0002-0420-4364"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Kafrelsheikh University, Kafr El-Sheikh 33516, Egypt."}], "LastName": "Shaldam", "ForeName": "Moataz A", "Initials": "MA"}, {"Identifier": ["0000-0001-9031-0149"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "El-Sherbeni", "ForeName": "Suzy A", "Initials": "SA"}, {"Identifier": ["0000-0001-8287-1026"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmaceutical Microbiology, Faculty of Pharmacy, Tanta University, Tanta 31527, Egypt."}], "LastName": "Elekhnawy", "ForeName": "Engy", "Initials": "E"}], "GrantList": [{"GrantID": "PNURSP2022R304", "Agency": "Princess Nourah bint Abdulrahman University", "Country": ""}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Pharmaceuticals (Basel)", "NlmUniqueID": "101238453", "ISSNLinking": "1424-8247"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Navon-Venezia S., Kondratyeva K., Carattoli A. Klebsiella pneumoniae: A major worldwide source and shuttle for antibiotic resistance. FEMS Microbiol. Rev. 2017;41:252\u2013275. doi: 10.1093/femsre/fux013.", "ArticleIdList": ["10.1093/femsre/fux013", "28521338"]}, {"Citation": "Negm W.A., El-Aasr M., Kamer A.A., Elekhnawy E. Investigation of the Antibacterial Activity and Efflux Pump Inhibitory Effect of Cycas thouarsii R. Br. Extract against Klebsiella pneumoniae Clinical Isolates. Pharmaceuticals. 2021;14:756. doi: 10.3390/ph14080756.", "ArticleIdList": ["10.3390/ph14080756", "PMC8401967", "34451853"]}, {"Citation": "Amorim A.G., Souza J.M., Santos R.C., Gullon B., Oliveira A., Santos L.F., Virgino A.L., Mafud A.C., Petrilli H.M., Mascarenhas Y.P. HPLC-DAD, ESI\u2013MS/MS, and NMR of Lycopene Isolated from P. guajava L. and Its Biotechnological Applications. Eur. J. Lipid Sci. Technol. 2018;120:1700330. doi: 10.1002/ejlt.201700330.", "ArticleIdList": ["10.1002/ejlt.201700330"]}, {"Citation": "Manabe H., Murakami Y., El-Aasr M., Ikeda T., Fujiwara Y., Ono M., Nohara T. Content variations of the tomato saponin esculeoside A in various processed tomatoes. J. Nat. Med. 2011;65:176\u2013179. doi: 10.1007/s11418-010-0443-4.", "ArticleIdList": ["10.1007/s11418-010-0443-4", "20652644"]}, {"Citation": "El-Aasr M., Miyashita H., Ikeda T., Lee J.-H., Yoshimitsu H., Nohara T., Murakami K. A new spirostanol glycoside from fruits of Solanum indicum L. Chem. Pharm. Bull. 2009;57:747\u2013748. doi: 10.1248/cpb.57.747.", "ArticleIdList": ["10.1248/cpb.57.747", "19571425"]}, {"Citation": "Khan U.M., Sevindik M., Zarrabi A., Nami M., Ozdemir B., Kaplan D.N., Selamoglu Z., Hasan M., Kumar M., Alshehri M.M. Lycopene: Food sources, biological activities, and human health benefits. Oxidative Med. Cell. Longev. 2021;2021:2713511. doi: 10.1155/2021/2713511.", "ArticleIdList": ["10.1155/2021/2713511", "PMC8626194", "34840666"]}, {"Citation": "Guo Y., Mao X., Zhang J., Sun P., Wang H., Zhang Y., Ma Y., Xu S., Lv R., Liu X. Oral delivery of lycopene-loaded microemulsion for brain-targeting: Preparation, characterization, pharmacokinetic evaluation and tissue distribution. Drug Deliv. 2019;26:1191\u20131205. doi: 10.1080/10717544.2019.1689312.", "ArticleIdList": ["10.1080/10717544.2019.1689312", "PMC6882477", "31738085"]}, {"Citation": "He H., Lu Y., Qi J., Zhu Q., Chen Z., Wu W. Adapting liposomes for oral drug delivery. Acta Pharm. Sin. B. 2019;9:36\u201348. doi: 10.1016/j.apsb.2018.06.005.", "ArticleIdList": ["10.1016/j.apsb.2018.06.005", "PMC6362257", "30766776"]}, {"Citation": "De Leo V., Di Gioia S., Milano F., Fini P., Comparelli R., Mancini E., Agostiano A., Conese M., Catucci L. Eudragit S100 entrapped liposome for curcumin delivery: Anti-oxidative effect in Caco-2 cells. Coatings. 2020;10:114. doi: 10.3390/coatings10020114.", "ArticleIdList": ["10.3390/coatings10020114"]}, {"Citation": "Conacher M., Alexander J., Brewer J.M. Oral immunisation with peptide and protein antigens by formulation in lipid vesicles incorporating bile salts (bilosomes) Vaccine. 2001;19:2965\u20132974. doi: 10.1016/S0264-410X(00)00537-5.", "ArticleIdList": ["10.1016/S0264-410X(00)00537-5", "11282208"]}, {"Citation": "Aburahma M.H. Bile salts-containing vesicles: Promising pharmaceutical carriers for oral delivery of poorly water-soluble drugs and peptide/protein-based therapeutics or vaccines. Drug Deliv. 2016;23:1847\u20131867. doi: 10.3109/10717544.2014.976892.", "ArticleIdList": ["10.3109/10717544.2014.976892", "25390191"]}, {"Citation": "Saifi Z., Rizwanullah M., Mir S.R., Amin S. Bilosomes nanocarriers for improved oral bioavailability of acyclovir: A complete characterization through in vitro, ex-vivo and in vivo assessment. J. Drug Deliv. Sci. Technol. 2020;57:101634. doi: 10.1016/j.jddst.2020.101634.", "ArticleIdList": ["10.1016/j.jddst.2020.101634"]}, {"Citation": "Albash R., El-Nabarawi M.A., Refai H., Abdelbary A.A. Tailoring of PEGylated bilosomes for promoting the transdermal delivery of olmesartan medoxomil: In-vitro characterization, ex-vivo permeation and in-vivo assessment. Int. J. Nanomed. 2019;14:6555. doi: 10.2147/IJN.S213613.", "ArticleIdList": ["10.2147/IJN.S213613", "PMC6699521", "31616143"]}, {"Citation": "Pavlovi\u0107 N., Golo\u010dorbin-Kon S., \u00d0ani\u0107 M., Stanimirov B., Al-Salami H., Stankov K., Mikov M. Bile acids and their derivatives as potential modifiers of drug release and pharmacokinetic profiles. Front. Pharmacol. 2018;9:1283. doi: 10.3389/fphar.2018.01283.", "ArticleIdList": ["10.3389/fphar.2018.01283", "PMC6237018", "30467479"]}, {"Citation": "Kumar G.P., Rajeshwarrao P. Nonionic surfactant vesicular systems for effective drug delivery\u2014An overview. Acta Pharm. Sin. B. 2011;1:208\u2013219. doi: 10.1016/j.apsb.2011.09.002.", "ArticleIdList": ["10.1016/j.apsb.2011.09.002"]}, {"Citation": "D\u2019Elia R.V., Woods S., Butcher W., McGahon J., Khadke S., Perrie Y., Williamson E.D., Roberts C.W. Exploitation of the bilosome platform technology to formulate antibiotics and enhance efficacy of melioidosis treatments. J. Control. Release. 2019;298:202\u2013212. doi: 10.1016/j.jconrel.2019.02.002.", "ArticleIdList": ["10.1016/j.jconrel.2019.02.002", "30731152"]}, {"Citation": "Waglewska E., Pucek-Kaczmarek A., Bazyli\u0144ska U. Novel surface-modified bilosomes as functional and biocompatible nanocarriers of hybrid compounds. Nanomaterials. 2020;10:2472. doi: 10.3390/nano10122472.", "ArticleIdList": ["10.3390/nano10122472", "PMC7763575", "33321762"]}, {"Citation": "Ahmad J., Singhal M., Amin S., Rizwanullah M., Akhter S., Amjad Kamal M., Haider N., Midoux P., Pichon C. Bile salt stabilized vesicles (bilosomes): A novel nano-pharmaceutical design for oral delivery of proteins and peptides. Curr. Pharm. Des. 2017;23:1575\u20131588. doi: 10.2174/1381612823666170124111142.", "ArticleIdList": ["10.2174/1381612823666170124111142", "28120725"]}, {"Citation": "Takehara M., Kuwa T., Inoue Y., Kitamura C., Honda M. Isolation and characterization of (15Z)-lycopene thermally generated from a natural source. Biochem. Biophys. Res. Commun. 2015;467:58\u201362. doi: 10.1016/j.bbrc.2015.09.122.", "ArticleIdList": ["10.1016/j.bbrc.2015.09.122", "26417685"]}, {"Citation": "Alvi S.S., Ansari I.A., Ahmad M.K., Iqbal J., Khan M.S. Lycopene amends LPS induced oxidative stress and hypertriglyceridemia via modulating PCSK-9 expression and Apo-CIII mediated lipoprotein lipase activity. Biomed. Pharmacother. 2017;96:1082\u20131093. doi: 10.1016/j.biopha.2017.11.116.", "ArticleIdList": ["10.1016/j.biopha.2017.11.116", "29174038"]}, {"Citation": "Zigangirova N.A., Morgunova E.Y., Fedina E.D., Shevyagina N.V., Borovaya T.G., Zhukhovitsky V.G., Kyle N.H., Petyaev I.M. Lycopene Inhibits Propagation of Chlamydia Infection. Scientifica. 2017;2017:1478625. doi: 10.1155/2017/1478625.", "ArticleIdList": ["10.1155/2017/1478625", "PMC5602621", "28948060"]}, {"Citation": "Ares M.A., Sansabas A., Rodr\u00edguez-Valverde D., Siqueiros-Cend\u00f3n T., Rasc\u00f3n-Cruz Q., Rosales-Reyes R., Jarillo-Quijada M., Alc\u00e1ntar-Curiel M.D., Cedillo M.L., Torres J. The interaction of Klebsiella pneumoniae with lipid rafts-associated cholesterol increases macrophage-mediated phagocytosis due to down regulation of the capsule polysaccharide. Front. Cell. Infect. Microbiol. 2019;9:255. doi: 10.3389/fcimb.2019.00255.", "ArticleIdList": ["10.3389/fcimb.2019.00255", "PMC6650577", "31380298"]}, {"Citation": "Ferreira R.L., da Silva B., Rezende G.S., Nakamura-Silva R., Pitondo-Silva A., Campanini E.B., Brito M.C., da Silva E.M., de Melo Freire C.C., da Cunha A.F. High prevalence of multidrug-resistant Klebsiella pneumoniae harboring several virulence and \u03b2-lactamase encoding genes in a Brazilian intensive care unit. Front. Microbiol. 2019;9:3198. doi: 10.3389/fmicb.2018.03198.", "ArticleIdList": ["10.3389/fmicb.2018.03198", "PMC6349766", "30723463"]}, {"Citation": "Pereira P.S., de Araujo C.F.M., Seki L.M., Zahner V., Carvalho-Assef A.P.D.A., Asensi M.D. Update of the molecular epidemiology of KPC-2-producing Klebsiella pneumoniae in Brazil: Spread of clonal complex 11 (ST11, ST437 and ST340) J. Antimicrob. Chemother. 2013;68:312\u2013316. doi: 10.1093/jac/dks396.", "ArticleIdList": ["10.1093/jac/dks396", "23070735"]}, {"Citation": "Paneru T.P. Surveillance of Klebsiella pneumoniae and antibiotic resistance a retrospective and comparative study through a period in Nepal. Dan. J. Med. Biol. Sci. 2015;1:29\u201336. doi: 10.6084/M9.FIGSHARE.1466724.V1.", "ArticleIdList": ["10.6084/M9.FIGSHARE.1466724.V1"]}, {"Citation": "Wasfi R., Elkhatib W.F., Ashour H.M. Molecular typing and virulence analysis of multidrug resistant Klebsiella pneumoniae clinical isolates recovered from Egyptian hospitals. Sci. Rep. 2016;6:38929. doi: 10.1038/srep38929.", "ArticleIdList": ["10.1038/srep38929", "PMC5177892", "28004732"]}, {"Citation": "Woodbury D.J., Richardson E.S., Grigg A.W., Welling R.D., Knudson B.H. Reducing liposome size with ultrasound: Bimodal size distributions. J. Liposome Res. 2006;16:57\u201380. doi: 10.1080/08982100500528842.", "ArticleIdList": ["10.1080/08982100500528842", "16556550"]}, {"Citation": "Alomrani A.H., El Maghraby G.M., Alanazi F.K., Al-Mohanna M.A., Alaiya A.A., Alsarra I.A. Liposomes for enhanced cytotoxic activity of bleomycin. Drug Dev. Res. 2011;72:265\u2013273. doi: 10.1002/ddr.20394.", "ArticleIdList": ["10.1002/ddr.20394"]}, {"Citation": "Ge X., Wei M., He S., Yuan W.-E. Advances of non-ionic surfactant vesicles (niosomes) and their application in drug delivery. Pharmaceutics. 2019;11:55. doi: 10.3390/pharmaceutics11020055.", "ArticleIdList": ["10.3390/pharmaceutics11020055", "PMC6410054", "30700021"]}, {"Citation": "Guan P., Lu Y., Qi J., Niu M., Lian R., Hu F., Wu W. Enhanced oral bioavailability of cyclosporine A by liposomes containing a bile salt. Int. J. Nanomed. 2011;6:965.", "ArticleIdList": ["PMC3124400", "21720508"]}, {"Citation": "Wilkhu J.S., McNeil S.E., Anderson D.E., Perrie Y. Characterization and optimization of bilosomes for oral vaccine delivery. J. Drug Target. 2013;21:291\u2013299. doi: 10.3109/1061186X.2012.747528.", "ArticleIdList": ["10.3109/1061186X.2012.747528", "30952177"]}, {"Citation": "Ahmed S., Kassem M.A., Sayed S. Bilosomes as promising nanovesicular carriers for improved transdermal delivery: Construction, in vitro optimization, ex vivo permeation and in vivo evaluation. Int. J. Nanomed. 2020;15:9783. doi: 10.2147/IJN.S278688.", "ArticleIdList": ["10.2147/IJN.S278688", "PMC7733410", "33324052"]}, {"Citation": "Abdelbary A.A., Abd-Elsalam W.H., Al-Mahallawi A.M. Fabrication of novel ultradeformable bilosomes for enhanced ocular delivery of terconazole: In vitro characterization, ex vivo permeation and in vivo safety assessment. Int. J. Pharm. 2016;513:688\u2013696. doi: 10.1016/j.ijpharm.2016.10.006.", "ArticleIdList": ["10.1016/j.ijpharm.2016.10.006", "27717916"]}, {"Citation": "Zhang X., Wu Y., Zhang M., Mao J., Wu Y., Zhang Y., Yao J., Xu C., Guo W., Yu B. Sodium cholate-enhanced polymeric micelle system for tumor-targeting delivery of paclitaxel. Int. J. Nanomed. 2017;12:8779. doi: 10.2147/IJN.S150196.", "ArticleIdList": ["10.2147/IJN.S150196", "PMC5732553", "29263668"]}, {"Citation": "El Maghraby G., Williams A., Barry B. Drug interaction and location in liposomes: Correlation with polar surface areas. Int. J. Pharm. 2005;292:179\u2013185. doi: 10.1016/j.ijpharm.2004.11.037.", "ArticleIdList": ["10.1016/j.ijpharm.2004.11.037", "15725564"]}, {"Citation": "Akhoond Zardini A., Mohebbi M., Farhoosh R., Bolurian S. Production and characterization of nanostructured lipid carriers and solid lipid nanoparticles containing lycopene for food fortification. J. Food Sci. Technol. 2018;55:287\u2013298. doi: 10.1007/s13197-017-2937-5.", "ArticleIdList": ["10.1007/s13197-017-2937-5", "PMC5756214", "29358821"]}, {"Citation": "Nazemiyeh E., Eskandani M., Sheikhloie H., Nazemiyeh H. Formulation and physicochemical characterization of lycopene-loaded solid lipid nanoparticles. Adv. Pharm. Bull. 2016;6:235. doi: 10.15171/apb.2016.032.", "ArticleIdList": ["10.15171/apb.2016.032", "PMC4961982", "27478786"]}, {"Citation": "Stojiljkovic N., Ilic S., Jakovljevic V., Stojanovic N., Stojnev S., Kocic H., Stojanovic M., Kocic G. The encapsulation of lycopene in nanoliposomes enhances its protective potential in methotrexate-induced kidney injury model. Oxidative Med. Cell. Longev. 2018;2018:2627917. doi: 10.1155/2018/2627917.", "ArticleIdList": ["10.1155/2018/2627917", "PMC5872654", "29725494"]}, {"Citation": "Rasul A., Khan M.I., Rehman M.U., Abbas G., Aslam N., Ahmad S., Abbas K., Shah P.A., Iqbal M., Al Subari A.M.A. In vitro characterization and release studies of combined nonionic surfactant-based vesicles for the prolonged delivery of an immunosuppressant model drug. Int. J. Nanomed. 2020;15:7937. doi: 10.2147/IJN.S268846.", "ArticleIdList": ["10.2147/IJN.S268846", "PMC7569247", "33116510"]}, {"Citation": "Allam A., Fetih G. Sublingual fast dissolving niosomal films for enhanced bioavailability and prolonged effect of metoprolol tartrate. Drug Des. Dev. Ther. 2016;10:2421.", "ArticleIdList": ["PMC4977085", "27536063"]}, {"Citation": "Gonelimali F.D., Lin J., Miao W., Xuan J., Charles F., Chen M., Hatab S.R. Antimicrobial properties and mechanism of action of some plant extracts against food pathogens and spoilage microorganisms. Front. Microbiol. 2018;9:1639. doi: 10.3389/fmicb.2018.01639.", "ArticleIdList": ["10.3389/fmicb.2018.01639", "PMC6066648", "30087662"]}, {"Citation": "Goldbeck J.C., Victoria F.N., Motta A., Savegnago L., Jacob R.G., Perin G., Lenardao E.J., da Silva W.P. Bioactivity and morphological changes of bacterial cells after exposure to 3-(p-chlorophenyl) thio citronellal. LWT Food Sci. Technol. 2014;59:813\u2013819. doi: 10.1016/j.lwt.2014.05.036.", "ArticleIdList": ["10.1016/j.lwt.2014.05.036"]}, {"Citation": "Abdelaziz A.A., Elbanna T.E., Sonbol F.I., Gamaleldin N.M., El Maghraby G.M. Optimization of niosomes for enhanced antibacterial activity and reduced bacterial resistance: In vitro and in vivo evaluation. Expert Opin. Drug Deliv. 2015;12:163\u2013180. doi: 10.1517/17425247.2014.942639.", "ArticleIdList": ["10.1517/17425247.2014.942639", "25135453"]}, {"Citation": "Aditya N., Espinosa Y.G., Norton I.T. Encapsulation systems for the delivery of hydrophilic nutraceuticals: Food application. Biotechnol. Adv. 2017;35:450\u2013457. doi: 10.1016/j.biotechadv.2017.03.012.", "ArticleIdList": ["10.1016/j.biotechadv.2017.03.012", "28377276"]}, {"Citation": "Ahmad R., Srivastava S., Ghosh S., Khare S.K. Phytochemical delivery through nanocarriers: A review. Colloids Surf. B Biointerfaces. 2021;197:111389. doi: 10.1016/j.colsurfb.2020.111389.", "ArticleIdList": ["10.1016/j.colsurfb.2020.111389", "33075659"]}, {"Citation": "Sultan A.A., El-Gizawy S.A., Osman M.A., El Maghraby G.M. Niosomes for oral delivery of nateglinide: In situ\u2013in vivo correlation. J. Liposome Res. 2018;28:209\u2013217. doi: 10.1080/08982104.2017.1343835.", "ArticleIdList": ["10.1080/08982104.2017.1343835", "28618876"]}, {"Citation": "Yu J., Rao L., Zhan L., Zhou Y., Guo Y., Wu X., Song Z., Yu F. Antibiofilm Activity of Small-Molecule ZY-214-4 Against Staphylococcus aureus. Front. Microbiol. 2021;91:618922. doi: 10.3389/fmicb.2021.618922.", "ArticleIdList": ["10.3389/fmicb.2021.618922", "PMC7886693", "33613488"]}, {"Citation": "Waterhouse A., Bertoni M., Bienert S., Studer G., Tauriello G., Gumienny R., Heer F.T., de Beer T.A.P., Rempfer C., Bordoli L., et al. SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Res. 2018;46:W296\u2013W303. doi: 10.1093/nar/gky427.", "ArticleIdList": ["10.1093/nar/gky427", "PMC6030848", "29788355"]}, {"Citation": "Ashraf K.U., Nygaard R., Vickery O.N., Erramilli S.K., Herrera C.M., McConville T.H., Petrou V.I., Giacometti S.I., Dufrisne M.B., Nosol K., et al. Structural basis of lipopolysaccharide maturation by the O-antigen ligase. Nature. 2022;604:371\u2013376. doi: 10.1038/s41586-022-04555-x.", "ArticleIdList": ["10.1038/s41586-022-04555-x", "35388216"]}, {"Citation": "Dovala D., Rath C.M., Hu Q., Sawyer W.S., Shia S., Elling R.A., Knapp M.S., Metzger L.E. Structure-guided enzymology of the lipid A acyltransferase LpxM reveals a dual activity mechanism. Proc. Natl. Acad. Sci. USA. 2016;113:E6064\u2013E6071. doi: 10.1073/pnas.1610746113.", "ArticleIdList": ["10.1073/pnas.1610746113", "PMC5068295", "27681620"]}, {"Citation": "Trott O., Olson A.J. AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J. Comput. Chem. 2010;31:455\u2013461. doi: 10.1002/jcc.21334.", "ArticleIdList": ["10.1002/jcc.21334", "PMC3041641", "19499576"]}, {"Citation": "DeRoo S.S., Pudalov N.J., Fu L.Y. Planning for a COVID-19 vaccination program. JAMA. 2020;323:2458\u20132459. doi: 10.1001/jama.2020.8711.", "ArticleIdList": ["10.1001/jama.2020.8711", "32421155"]}, {"Citation": "Seleem N.M., Abd El Latif H.K., Shaldam M.A., El-Ganiny A. Drugs with new lease of life as quorum sensing inhibitors: For combating MDR Acinetobacter baumannii infections. Eur. J. Clin. Microbiol. Infect. Dis. 2020;39:1687\u20131702. doi: 10.1007/s10096-020-03882-z.", "ArticleIdList": ["10.1007/s10096-020-03882-z", "PMC7180647", "32328851"]}, {"Citation": "Sultan A.A., El-Gizawy S.A., Osman M.A., El Maghraby G.M. Peceosomes for oral delivery of glibenclamide: In vitro in situ correlation. J. Drug Deliv. Sci. Technol. 2017;41:303\u2013309. doi: 10.1016/j.jddst.2017.08.003.", "ArticleIdList": ["10.1016/j.jddst.2017.08.003"]}, {"Citation": "Abdelbary A.A., AbouGhaly M.H. Design and optimization of topical methotrexate loaded niosomes for enhanced management of psoriasis: Application of Box\u2013Behnken design, in-vitro evaluation and in-vivo skin deposition study. Int. J. Pharm. 2015;485:235\u2013243. doi: 10.1016/j.ijpharm.2015.03.020.", "ArticleIdList": ["10.1016/j.ijpharm.2015.03.020", "25773359"]}, {"Citation": "Habib B.A., Sayed S., Elsayed G.M. Enhanced transdermal delivery of ondansetron using nanovesicular systems: Fabrication, characterization, optimization and ex-vivo permeation study-Box-Cox transformation practical example. Eur. J. Pharm. Sci. 2018;115:352\u2013361. doi: 10.1016/j.ejps.2018.01.044.", "ArticleIdList": ["10.1016/j.ejps.2018.01.044", "29407555"]}, {"Citation": "Khan K. The concept of dissolution efficiency. J. Pharm. Pharmacol. 1975;27:48\u201349. doi: 10.1111/j.2042-7158.1975.tb09378.x.", "ArticleIdList": ["10.1111/j.2042-7158.1975.tb09378.x", "235616"]}, {"Citation": "Higuchi T. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J. Pharm. Sci. 1963;52:1145\u20131149. doi: 10.1002/jps.2600521210.", "ArticleIdList": ["10.1002/jps.2600521210", "14088963"]}, {"Citation": "Costa P., Lobo J.M.S. Modeling and comparison of dissolution profiles. Eur. J. Pharm. Sci. 2001;13:123\u2013133. doi: 10.1016/S0928-0987(01)00095-1.", "ArticleIdList": ["10.1016/S0928-0987(01)00095-1", "11297896"]}, {"Citation": "CLSI . Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. Clinical and Laboratory Standards Institute; Wayne, NJ, USA: 2020. Supplement M100."}, {"Citation": "Negm W.A., El-Kadem A.H., Elekhnawy E., Attallah N.G., Al-Hamoud G.A., El-Masry T.A., Zayed A. Wound-Healing Potential of Rhoifolin-Rich Fraction Isolated from Sanguisorba officinalis Roots Supported by Enhancing Re-Epithelization, Angiogenesis, Anti-Inflammatory, and Antimicrobial Effects. Pharmaceuticals. 2022;15:178. doi: 10.3390/ph15020178.", "ArticleIdList": ["10.3390/ph15020178", "PMC8874642", "35215291"]}, {"Citation": "Magiorakos A.-P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M., Giske C., Harbarth S., Hindler J., Kahlmeter G., Olsson-Liljequist B. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268\u2013281. doi: 10.1111/j.1469-0691.2011.03570.x.", "ArticleIdList": ["10.1111/j.1469-0691.2011.03570.x", "21793988"]}, {"Citation": "Attallah N.G., Elekhnawy E., Negm W.A., Hussein I.A., Mokhtar F.A., Al-Fakhrany O.M. In Vivo and In Vitro Antimicrobial Activity of Biogenic Silver Nanoparticles against Staphylococcus aureus Clinical Isolates. Pharmaceuticals. 2022;15:194. doi: 10.3390/ph15020194.", "ArticleIdList": ["10.3390/ph15020194", "PMC8878289", "35215306"]}, {"Citation": "Elekhnawy E., Negm W.A., El-Aasr M., Kamer A.A., Alqarni M., Batiha G.E.-S., Obaidullah A.J., Fawzy H.M. Histological assessment, anti-quorum sensing, and anti-biofilm activities of Dioon spinulosum extract: In vitro and in vivo approach. Sci. Rep. 2022;12:180. doi: 10.1038/s41598-021-03953-x.", "ArticleIdList": ["10.1038/s41598-021-03953-x", "PMC8742103", "34996996"]}, {"Citation": "Van Hoek M.L., Kaushal A., Bishop B.M., Barksdale S.M. Intraperitoneal treatment with antimicrobial peptide rescues mice from a pulmonary Francisella infection. bioRxiv. 2019 doi: 10.1101/603233.", "ArticleIdList": ["10.1101/603233"]}, {"Citation": "Alotaibi B., Negm W.A., Elekhnawy E., El-Masry T.A., Elharty M.E., Saleh A., Abdelkader D.H., Mokhtar F.A. Antibacterial activity of nano zinc oxide green-synthesised from Gardenia thailandica triveng. Leaves against Pseudomonas aeruginosa clinical isolates: In vitro and in vivo study. Artif. Cells Nanomed. Biotechnol. 2022;50:96\u2013106. doi: 10.1080/21691401.2022.2056191.", "ArticleIdList": ["10.1080/21691401.2022.2056191", "35361019"]}, {"Citation": "Alert O. Guidance for Industry Estimating the Maximum Safe Starting Dose in Initial Clinical Trials for Therapeutics in Adult Healthy Volunteers. U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER); Silver Spring, MD, USA: 2005."}, {"Citation": "Alotaibi B., Negm W.A., Elekhnawy E., El-Masry T.A., Elseady W.S., Saleh A., Alotaibi K.N., El-Sherbeni S.A. Antibacterial, Immunomodulatory, and Lung Protective Effects of Boswelliadalzielii Oleoresin Ethanol Extract in Pulmonary Diseases: In Vitro and in Vivo Studies. Antibiotics. 2021;10:1444. doi: 10.3390/antibiotics10121444.", "ArticleIdList": ["10.3390/antibiotics10121444", "PMC8698344", "34943656"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "8", "Day": "3"}, {"Year": "2022", "Month": "8", "Day": "18"}, {"Year": "2022", "Month": "8", "Day": "22"}, {"Year": "2022", "Month": "9", "Day": "23", "Hour": "1", "Minute": "40"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "9", "Day": "24", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "8", "Day": "24"}], "PublicationStatus": "epublish", "ArticleIdList": ["36145264", "PMC9505130", "10.3390/ph15091043", "ph15091043"]}}], "PubmedBookArticle": []}